HAEMONETICS CORP Common Stock Shares Outstanding

• HAEMONETICS CORP showed a decrease of -5.1% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from HAEMONETICS CORP's annual report (Form 10-K), filed with the SEC on May 21, 2025.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), HAEMONETICS CORP's Common Stock Shares Outstanding has grown by 89.5%.
• Historical annual values: Fiscal year 2025: 48.22 million shares | Fiscal year 2024: 50.79 million shares | Fiscal year 2023: 50.45 million shares | Fiscal year 2022: 51.12 million shares | Fiscal year 2021: 50.87 million shares | Fiscal year 2020: 50.32 million shares | Fiscal year 2019: 51.02 million shares | Fiscal year 2018: 52.34 million shares | Fiscal year 2017: 52.26 million shares | Fiscal year 2016: 50.93 million shares | Fiscal year 2015: 51.67 million shares | Fiscal year 2014: 52.04 million shares | Fiscal year 2013: 51.03 million shares | Fiscal year 2012: 50.60 million shares | Fiscal year 2011: 25.66 million shares | Fiscal year 2010: 25.44 million shares.
• Data sourced from SEC EDGAR public filings as of June 24, 2026.

Last verified: June 24, 2026